Status:
TERMINATED
Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
Lead Sponsor:
Corewell Health East
Conditions:
Catheter; Infection (Indwelling Catheter)
Catheter Infection
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
Over the last decade, there has been great emphasis on reducing the incidence of hospital-acquired infections, including catheter-associated UTI (CAUTI). This study will evaluate the effectiveness of ...
Detailed Description
Indwelling urinary catheters are routinely used in the care of hospitalized patients for a variety of reasons, including monitoring of urine output in critically ill patients, relief of urinary obstru...
Eligibility Criteria
Inclusion
- Provide written informed consent and the willingness and ability to comply with all aspects of study requirements
- Male
- Inpatients ≥ 18 years of age with an indwelling catheter in place for at least 5 days with a plan for removal
Exclusion
- Patients planned for discharge with an indwelling catheter in place
- Patients unable to report urinary symptoms accurately
- Patients with hyper-sensitivity or allergic reaction to Betadine, iodine, shellfish or other related compounds
- Clinical signs or symptoms of urinary tract infection at the time of consent
- Patients currently being treated for UTI
- Patients currently taking any antibiotic medication, other than vancomycin, linezolid, daptomycin, clindamycin, or metronidazole.
- Patients already taking medications known to potentially irritate the bladder, such as, but not limited to, cyclophosphamide, ifosfamide, and other chemotherapeutic agents
- Patients with history of bladder cancer, pelvic radiation or interstitial cystitis
- Patients unable to comply with study requirements
- Any other condition which, per investigators' judgment, may increase patient risk and/or impede the reliability of study data
Key Trial Info
Start Date :
March 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 22 2018
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT03447639
Start Date
March 29 2018
End Date
October 22 2018
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beaumont Hospital
Royal Oak, Michigan, United States, 48073